/ Home / Product Center / APIs / Others /

Ivacaftor

Ivacaftor
CAS
873054-44-5
MF
C24H28N2O3
MW
392.49
Purity
98%
Melting point
212-215°C
Solubility
DMSO (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
Appearance
White to Light Brown solid
Storage Temp
Refrigerator
Indication
Cystic fibrosis
Description

In January 2012, the US FDA approved ivacaftor for the treatment of cystic fibrosis (CF) in patients who have the G551D mutation of the CF transmembrane regulator (CFTR) and are at least 6 years old.